Analysts: GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,704.10INR
23 Oct 2014
Price Change (% chg)

Rs-5.45 (-0.20%)
Prev Close
Rs2,709.55
Open
Rs2,720.00
Day's High
Rs2,729.95
Day's Low
Rs2,700.00
Volume
3,053
Avg. Vol
19,033
52-wk High
Rs3,054.50
52-wk Low
Rs2,365.00

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- December 25 Oct 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 2
(3) HOLD 6 6 6 6
(4) UNDERPERFORM 6 7 7 7
(5) SELL 2 2 2 2
No Opinion 0 0 0 0
Mean Rating 3.44 3.47 3.47 3.39

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-14 11 27,824.70 32,241.70 25,202.00 30,784.80
Year Ending Dec-15 10 30,568.30 32,915.60 27,102.00 34,192.00
Earnings (per share)
Year Ending Dec-14 11 62.06 82.27 51.20 84.67
Year Ending Dec-15 10 71.79 89.40 57.70 93.38
LT Growth Rate (%) 1 16.80 16.80 16.80 15.00

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-10 5,833.20 5,819.90 13.30 0.23
Quarter Ending Jun-10 5,212.33 4,979.30 233.03 4.47
Quarter Ending Mar-10 5,193.00 5,411.00 218.00 4.20
Quarter Ending Dec-09 4,127.20 4,444.00 316.80 7.68
Quarter Ending Sep-09 5,023.25 5,118.10 94.85 1.89
Earnings (per share)
Quarter Ending Sep-10 18.70 18.70 0.00 0.00
Quarter Ending Jun-10 17.80 16.40 1.40 7.87
Quarter Ending Sep-09 15.60 16.70 1.10 7.05
Quarter Ending Jun-09 14.30 15.50 1.20 8.39
Quarter Ending Mar-09 15.00 14.80 0.20 1.33

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-14 27,824.70 27,935.60 27,935.60 28,098.90 30,784.80
Year Ending Dec-15 30,568.30 30,644.50 30,644.50 31,166.20 34,192.00
Earnings (per share)
Year Ending Dec-14 62.06 63.15 63.15 64.36 84.67
Year Ending Dec-15 71.79 72.32 72.32 74.62 93.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Motilal Oswal Securities Ltd.
$58.00
Provider: Axis Capital Limited
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks